[EN] AMINOHETEROARYL COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS AMINOHÉTÉROARYLES ET LEURS UTILISATIONS
申请人:[en]BEIJING ERAI THERAPEUTICS CO., LTD.
公开号:WO2022147694A1
公开(公告)日:2022-07-14
Provided herein are novel compounds (e.g., Formula I, II, III, or IV), pharmaceutical compositions, and methods of using the same. The compounds herein can typically induce UCP-1 expression and/or browning of white adipose tissues. The compounds herein can also be used for treating a variety of diseases or disorders, such as a metabolic disease or disorder such as obesity and/or diabetes (e.g., Type 2 diabetes) and/or a liver disease or disorder such as NASH and/or non-alcoholic fatty liver disease.